Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, SH | - |
dc.contributor.author | Park, SY | - |
dc.contributor.author | Kim-Pak, Y | - |
dc.contributor.author | Lee, HK | - |
dc.contributor.author | Park, KS | - |
dc.contributor.author | Shin, KH | - |
dc.contributor.author | Ohuchi, K | - |
dc.contributor.author | Shin, HK | - |
dc.contributor.author | Keum, SR | - |
dc.contributor.author | Lim, SS | - |
dc.date.accessioned | 2024-01-21T03:36:24Z | - |
dc.date.available | 2024-01-21T03:36:24Z | - |
dc.date.created | 2021-09-02 | - |
dc.date.issued | 2006-03 | - |
dc.identifier.issn | 0009-2363 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/135732 | - |
dc.description.abstract | Fifteen chalcones and three thiazolidinedione (TZD) chalcones were prepared to evaluate their peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand-binding activities. Among the three TZDs, one compound possessed PPAR-gamma transactivation potential, while the others showed antagonistic activity against PPAR-gamma transactivation. Among the chalcones, compound 5 was the most potent, and structure-activity relationship studies indicated that a methoxyl group in position C-4 and hydroxyl group in position C-4' or 5' in chalcone plays a key role in determining the potency of PPAR-gamma activation. | - |
dc.language | English | - |
dc.publisher | PHARMACEUTICAL SOC JAPAN | - |
dc.subject | HYPOGLYCEMIC ACTIVITY | - |
dc.subject | FLAVONE DERIVATIVES | - |
dc.subject | ALDOSE REDUCTASE | - |
dc.subject | CHALCONES | - |
dc.subject | ADIPOCYTES | - |
dc.subject | TARGETS | - |
dc.subject | TISSUES | - |
dc.title | Synthesis and PPAR-gamma ligand-binding activity of the new series of 2 '-hydroxychalcone and thiazolidinedione derivatives | - |
dc.type | Article | - |
dc.identifier.doi | 10.1248/cpb.54.368 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | CHEMICAL & PHARMACEUTICAL BULLETIN, v.54, no.3, pp.368 - 371 | - |
dc.citation.title | CHEMICAL & PHARMACEUTICAL BULLETIN | - |
dc.citation.volume | 54 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 368 | - |
dc.citation.endPage | 371 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000236227000018 | - |
dc.identifier.scopusid | 2-s2.0-33645217958 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | HYPOGLYCEMIC ACTIVITY | - |
dc.subject.keywordPlus | FLAVONE DERIVATIVES | - |
dc.subject.keywordPlus | ALDOSE REDUCTASE | - |
dc.subject.keywordPlus | CHALCONES | - |
dc.subject.keywordPlus | ADIPOCYTES | - |
dc.subject.keywordPlus | TARGETS | - |
dc.subject.keywordPlus | TISSUES | - |
dc.subject.keywordAuthor | PPAR-gamma | - |
dc.subject.keywordAuthor | 2 &apos | - |
dc.subject.keywordAuthor | ,5 &apos | - |
dc.subject.keywordAuthor | -dihydroxy-4-methoxychalcone | - |
dc.subject.keywordAuthor | chalconyl-thiazolidinedione | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.